Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale

Maturitas ◽  
2005 ◽  
Vol 51 (3) ◽  
pp. 236-245 ◽  
Author(s):  
Bresilda Sierra ◽  
Luis A. Hidalgo ◽  
Peter A. Chedraui
Keyword(s):  
Author(s):  
Eleni Armeni ◽  
Areti Augoulea ◽  
Anastasia Palaiologou ◽  
Foteini Christidi ◽  
Anastasia Soureti ◽  
...  

2018 ◽  
Vol 41 ◽  
pp. 100-111 ◽  
Author(s):  
Naice E.S. Monteiro ◽  
Lívia D. Queirós ◽  
Danielle B. Lopes ◽  
Adriana O. Pedro ◽  
Gabriela A. Macedo

Maturitas ◽  
1996 ◽  
Vol 27 ◽  
pp. 93
Author(s):  
SC Ho ◽  
SG Chan ◽  
V Yip ◽  
C Chan ◽  
CL Law

Maturitas ◽  
2012 ◽  
Vol 71 ◽  
pp. S65-S66
Author(s):  
A. Augoulea ◽  
K. Kazani ◽  
E. Tsoka ◽  
P. Thoda ◽  
V. Gregoriou ◽  
...  
Keyword(s):  

Maturitas ◽  
2018 ◽  
Vol 108 ◽  
pp. 13-17 ◽  
Author(s):  
Marieke Arts-de Jong ◽  
Liselore L. van Westerop ◽  
Nicoline Hoogerbrugge ◽  
Leon F. Massuger ◽  
Angela H. Maas ◽  
...  

2021 ◽  
Author(s):  
Remi Yoshikata ◽  
Khin Zay Yar Myint ◽  
Hiroaki Ohta ◽  
Yoko Ishigaki

Abstract Introduction: Equol, an isoflavone derivative whose chemical structure is similar to estrogen, is considered as a potentially effective agent for relieving climacteric symptoms, for the prevention of the lifestyle-related diseases, and for aging care in post-menopausal women. We investigated the effect of an equol-containing supplement on metabolism and aging, and climacteric symptoms, with respect to internally-produced equol in post-menopausal women.Methods: A single center, randomized controlled trial (registration number: UMIN000030975) on 57 post-menopausal Japanese women (mean age: 56±5.37 years), was conducted. Twenty-seven women received the equol supplement, while the remaining received Control. Metabolic and aging-related biomarkers were compared before and after the 3-month intervention. Climacteric symptoms were assessed every month using a validated self-administered questionnaire in Japanese post-menopausal women. Results: Three months post intervention, the treatment group showed significant improvement in climacteric symptoms, when compared to the Control group (81% vs. 53% respectively, p=0.045). We did not observe any beneficial effect on metabolic and aging-related biomarkers in the intervention group. However, in certain populations significant improvement in skin auto-fluorescence, which is a measurement of AGE skin products, and visceral fat area was observed, especially among equol producers. Conclusion: Women receiving equol supplement showed improved climacteric symptoms. This study offered a new hypothesis that there may be a synergy between supplemented equol and endogenously-produced equol to improve skin aging and visceral fat in certain populations.


Sign in / Sign up

Export Citation Format

Share Document